March 28, 2016 – Dr. Roger L. Garceau, the former Executive Vice President and Chief Medical Officer (CMO) of NPS Pharmaceuticals, Inc. was appointed to Entera’s board of directors. Dr. Garceau brings more than 30 years of experience to Entera's board. Dr. Garceau served in a number of senior leadership positions at Sanofi-Aventis as well as in other pharmaceutical companies.
Innovative Technology Platform
Entera's innovative technology enables oral drug delivery of large molecules
Pipeline of Drug Development
Entera conducts clinical trials of three oral drugs based on a proven active compound
Experienced Management Team
The managers of Entera have more than 50 years of experience in drug development